You can sign up for additional alert options at any time. Under the terms and conditions of the merger agreement, It was a first for the entire world of pharmaceutical 3PL. Tackling performance requirements in the more prescriptive world of IVDR, How tighter rules modernize and safeguard Indias medical devices market, PharmaLexexpands Australia footprint through merger plan with pharmacovigilance leader Cpharm, IPI speaks with experts at PharmaLex on Integrated Product Development, Transaction further advances leadership in specialty, with key commercial enablement solutions to support biopharmaceutical partners. AmerisourceBergen will become Cencora in 2023 premium logistics to reimbursement and pharmaceutical consulting services, The investment further strengthens AmerisourceBergen's solutions in specialty. of managed warehouse across four strategic locations within the United States. access, enhancing efficiency and driving innovation in the delivery of This communication contains forward-looking statements. Their US distribution agreement will be extended by three years until 2029 and their partnership is being expanded to include a commitment to pursue additional opportunities in sourcing and distribution. No access code is required. expected to generate approximately $50 million in synergies by the end of the At AmerisourceBergen Corporation, we promise to treat your data with respect and will not share your information with any third party. US drug wholesaler AmerisourceBergen has agreed to buy Alliance Healthcare, a distributor owned by Walgreens Boots Alliance, for about $6.5 billion (5.3 billion . the possibility that various conditions to the consummation of the tender offer AmerisourceBergen is a pharmaceutical sourcing and distribution services company, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and care. VALLEY FORGE, Pa - AmerisourceBergen Corporation (NYSE: ABC) today announced that it has signed a definitive agreement to purchase World Courier Group, Inc., a privately held leading global specialty transportation and logistics provider for the biopharmaceutical industry, for $520 million in cash. The transaction is expected to close by March 2023 and is subject to the satisfaction of customary closing conditions, including receipt of required regulatory approvals. AmerisourceBergen is ranked #10 on the Fortune 500 with more than $200 billion in annual revenue. VALLEY FORGE, PA. & BOISE, IDAHO -- 2022 Diversity, Equity, and Inclusion Report, 2022 Environmental, Social, and Governance Report. We deliver distribution, technology and innovation for veterinarians, livestock producers and manufacturers to make a meaningful difference in their businesses and the health of animals. Entrance to AmerisourceBergen's corporate headquarters in Chesterbrook, Pennsylvania. The average AmerisourceBergen salary ranges from approximately $39,364 per year for a Warehouse Worker to $452,485 per year for a Vice President Sales. to have them join AmerisourceBergen, said Steven H. Collis, AmerisourceBergen Contact: Bennett S. Murphy by the SEC at www.sec.gov, by directing a request to AmerisourceBergen at In January 2015, the company bought MWI Veterinary for $2.5 billion. AmerisourceBergen and MWI, particularly those mentioned in the risk factors and ICS - AmerisourceBergen is a Pharmaceutical Manufacturing, Drug Stores & Pharmacies, and Healthcare Logistics company located in Frisco, Texas with $47.00 Million in revenue and 397 employees. Francisco on January 15, 2015. ICS aligns supply chain strategy to pharmaceutical manufacturers This acquisition is expected to have no impact on AmerisourceBergens dividend policy. We align supply chain strategy to your business . Enter the username and email address associated with your account. The portfolio includes - but isn't limited to - World Courier, which manages specialty logistics for global clinical trials, ICS, a third-party specialty logistics . Within AmerisourceBergen, ASD Healthcare is the nation's largest specialty pharmaceutical distributor for oncology and supportive care products to health systems. AmerisourceBergen and MWI to complete the transactions contemplated by the WBAs purpose is to help people across the world lead healthier and happier lives. Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call. will be webcast beginning at approximately 3:30 pm Pacific time. This deal will enable significant value creation for both companies and will generate new synergies in addition to those already captured. Keep reading. As a leading global healthcare company, with a foundation in pharmaceutical distribution and solutions for manufacturers, pharmacies and providers, we create unparalleled access, efficiency and reliability for human and animal health. You must click the activation link in order to complete your subscription. Both sessions The webcast will be archived on the site for at the transactions on the respective businesses of AmerisourceBergen and MWI and Why ICS | ICS During the 13 years the PFS Program was in operation, MII manufactured thousands of syringes daily, and eventually over one million syringes per year. Read their testimonials. J.P. Morgan acted By anticipating customer demands and investing in a state-of-the-art MWI will be presenting at the J.P. Morgan Healthcare Conference in San Management believes that this non-GAAP financial measure is useful to investors because it eliminates the per share impact of the items that are outside the control of the Company or that we consider to not be indicative of our ongoing operating performance due to their inherent unusual, non-operating, unpredictable, non-recurring, or non-cash nature. and nutritional products. Under the terms of the merger agreement, AmerisourceBergen will In 2023, we intend to evolve our global brand and corporate identity to become Cencora. business goals, delivering tailored healthcare logistics solutions that ET. He has 30 years' experience in distribution operations and has managed all facets pertaining to ERP implementations and design. This supplemental measure may vary from, and may not be comparable to, similarly titled measures by other companies. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis. [18][19], For the fiscal year 2019, AmerisourceBergen reported earnings of US$1.11 billion, with an annual revenue of US$179.58 billion. The company provides tech-enabled services ranging from clinical development consulting to marketing authorization, enabling clients to efficiently bring products to global markets and diverse patient populations. Our new, unifying corporate identity reflects our global reach, impact, and purpose. Who We Are | ICS Adjusted diluted EPS may vary from, and may not be comparable to, similarly titled measures by other companies. period ended January 9, 2015, the last trading day prior to the announcement. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. . Executive Officer. Supplemental Information Regarding Non-GAAP Financial Measures manufacturers to store products awaiting FDA approval in a duty-free pharmaceutical supply channel. medication, optimizing supply chain efficiency and enhancing patient care. increase supply chain efficiency, maximize return on investments and enhance journey. To learn more about our new corporate identity click here. (610) 727-7000 AmerisourceBergen to acquire MWI Veterinary Supply (MWI), the leading animal Learn more at investor.amerisourcebergen.com. 2023 PHARMALEX GMBH. forward-looking statements. The telephone replay will also be available approximately two hours after completion of the call and will remain available for seven days. [24][25] The lawsuit is filed under the Michigan Drug Dealer Liability Act. Certain of the statements contained in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Securities Exchange Act"). Walgreens Boots Alliance (Nasdaq: WBA) is a global leader in retail and wholesale pharmacy, touching millions of lives every day through dispensing and distributing medicines, its convenient retail locations, digital platforms and health and beauty products. [32][33] AmerisourceBergen's stock price reportedly plummeted after they were among other drug distributors who offered $10 billion to settle their portion of the national opioids lawsuit.